GSK presents new data backing shingles vaccine

GSK presents new data backing shingles vaccine The firm says data show that when Shingrix was given to patients aged 50 years or over at the same time as an unadjuvanted seasonal flu vaccine, both vaccines were well tolerated and the immune response to each vaccine was similar whether it was administered at the same time or separately. On the ... Read More »

Working Towards What You Already Have

Working Towards What You Already Have The American investment banker was at the pier of a small coastal Mexican village when a small boat with just one fisherman docked. Inside the small boat were several large yellow fin tuna. The American complimented the Mexican on the quality of his fish and asked how long it took to catch them. The ... Read More »

Leadership In Making

Leadership In Making At VIVAN we believe in making of Honest, futuristic, competent, inspiring, intelligent leader. Leadership is not necessarily an inborn trait, which can be developed with proper nurturing.   We mould every individual at VIVAN to give their best possible for betterment of organization, individual and society. We give them the chance to play with mud and create ... Read More »

Bristol Opdivo discount in kidney cancer changes minds at NICE

Bristol Opdivo discount in kidney cancer changes minds at NICE In July, England’s cost watchdogs weren’t keen on covering Bristol-Myers Squibb’s Opdivo for kidney cancer patients. But the New Jersey drugmaker has said the magic word: discount. Friday, the National Institute for Health and Care Excellence announced a flip-flop on the idea, backing the med for NHS use in previously ... Read More »

Determination and Persistence

Determination and Persistence This is a real life story of engineer John Roebling building the Brooklyn Bridge in New York, USA back in 1870. The bridge was completed in 1883, after 13 years. In 1883, a creative engineer named John Roebling was inspired by an idea to build a spectacular bridge connecting New York with the Long Island. However bridge ... Read More »

Our Culture

Our Culture At VIVAN, our performance-oriented culture and responsible approach are the foundations of our success. We recognize that our business depends on the creativity, innovation, dedication and performance of our Associates. We encourage our Associates to focus on achievements through collaboration, innovation and team work. We support our Associates to take freedom with responsibility, which eventually guides them to ... Read More »

Pharma cos may report low key performance in Q2 FY17

Pharma cos may report low key performance in Q2 FY17   Domestic pharmaceutical companies are likely to report subdued sales, EBITDA and PAT figures in the second quarter of this fiscal, even as the formulations business may see a strong recovery, a report said. “We expect the pharmaceutical companies to report subdued performance on sales, EBITDA and PAT front in ... Read More »

Gilead (GILD) Should Buy This Company

Gilead (GILD) Should Buy This Company The investment bank Evercore ISI surveyed 244 biotech industry observers. The primary goal was for them to identify the biotech company they thought mostly likely to be acquired in the next year and who they thought should buy it. Incyte (INCY) was the top pick for an acquisition target, and Gilead Sciences (GILD) won out ... Read More »

Pfizer’s Sutent comes up big in adjuvant kidney cancer trial

Pfizer’s Sutent comes up big in adjuvant kidney cancer trial COPENHAGEN, Denmark–Pfizer’s kidney-cancer fighter Sutent is an aging drug–but it may just have one more label expansion up its sleeve. Among patients with localized kidney cancer that’s been surgically removed–a group considered high-risk for relapse–the med bested placebo in a Phase III study at improving disease-free survival, the New York pharma ... Read More » • Free Website Templates - Downlaod Full Themes